EP1761528

5-amínó-2,4,7-tríoxó-3,4,7,8-tetrahýdró-2H-pýrídó(2,3-d)pýrimidín afleiður og skyld efnasambönd fyrir meðhöndlun á krabbameini

Status:
EP Einkaleyfi útrunnið
EP appl. date:
10.6.2005
EP published:
9.1.2008
EP application number:
05751244.4

EP translation filed:
11.3.2008
Grant published:
15.4.2008
EPO information:
European Patent Register

Max expiry date:
9.6.2025
Expiry date:
9.6.2025

Title:
5-AMINO-2,4,7-TRIOXO-3,4,7,8-TETRAHYDRO-2H-PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF CANCER

Timeline

Today

10.6.2005EP application

9.1.2008EP Publication

11.3.2008Translation submitted

15.4.2008Registration published

9.6.2025Expires

Owner

Name:
Japan Tobacco, Inc.
Address:
1-1, Toranomon 4-chome, Minato-ku, 105 6927, Tokyo, JP

Inventor

Name:
SAKAI, Toshiyuki
Address:
Kyoto, JP

Name:
KAWASAKI, H.Cen.Pharm.Res.Inst.Japan Tobacco Inc.
Address:
Osaka, JP

Name:
ABE, H.Cen.Pharma.Res.Inst.of Japan Tobacco Inc.
Address:
Osaka, JP

Name:
HAYAKAWA,KCen.Pharm.Res.Inst of Japan Tobacco Inc
Address:
Osaka, JP

Name:
IIDA, T.Cen.Pharm.Res.Inst. of Japan Tobacco Inc.
Address:
Osaka, JP

Name:
KIKUCHI,S.Cen.Pharm.Res.Inst.of Japan Tobacco Inc
Address:
Osaka, JP

Name:
YAMAGUCHI,T.Cen.Pharm.Res.Inst.Japan Tobacco Inc.
Address:
Osaka, JP

Name:
NANAYAMA,TCen.Pharm.Res.Inst.of Japan Tobacco Inc
Address:
Osaka, JP

Name:
KURACHI,HCen.Pharma.Res.Inst.of Japan Tobacco Inc
Address:
Osaka, JP

Name:
TAMARU,M.Cen.Pharma.Res.Inst.of Japan Tobacco Inc
Address:
Osaka, JP

Name:
HORI, Y.Cen.Pharma.Res.Inst.of Japan Tobacco Inc.
Address:
Osaka, JP

Name:
TAKAHASHI, MCen.Pharma.Res.Inst. Japan TobaccoInc
Address:
Osaka, JP

Name:
YOSHIDA, T.Cen.Pharma.Res.Inst. Japan TobaccoInc
Address:
Kanagawa, JP

Agent

Name:
Árnason Faktor ehf.
Address:
Guðríðarstíg 2-4, 113, Reykjavík,

Priority

Number:
2004174770
Date:
11.6.2004
Country:
JP

Number:
2004327111
Date:
10.11.2004
Country:
JP

Supplementary protection

SPC number:
SPC102

Annual fees

Number

Paid

Expires

Payer

Number: 4

Paid: 2.6.2008

Expires:

Payer:

Number: 5

Paid: 2.4.2009

Expires: 1.6.2010

Payer:

Number: 6

Paid: 31.3.2010

Expires: 1.6.2011

Payer: Sigurjónsson & Thor ehf.

Number: 7

Paid: 4.5.2011

Expires: 9.6.2012

Payer: Sigurjónsson & Thor ehf.

Number: 8

Paid: 7.5.2012

Expires: 9.6.2013

Payer: Sigurjónsson & Thor ehf.

Number: 9

Paid: 8.5.2013

Expires: 9.6.2014

Payer: Sigurjónsson & Thor ehf.

Number: 10

Paid: 7.5.2014

Expires: 9.6.2015

Payer: Árnason Faktor

Number: 11

Paid: 7.5.2015

Expires: 9.6.2016

Payer: Árnason Faktor

Number: 12

Paid: 10.5.2016

Expires: 9.6.2017

Payer: Árnason Faktor

Number: 13

Paid: 8.5.2017

Expires: 9.6.2018

Payer: Árnason Faktor

Number: 14

Paid: 14.5.2018

Expires: 9.6.2019

Payer: Árnason Faktor

Number: 15

Paid: 8.5.2019

Expires: 9.6.2020

Payer: Árnason Faktor

Number: 16

Paid: 5.5.2020

Expires: 9.6.2021

Payer: Árnason Faktor ehf.

Number: 17

Paid: 11.5.2021

Expires: 9.6.2022

Payer: Árnason Faktor ehf.

Number: 18

Paid: 6.5.2022

Expires: 9.6.2023

Payer: Árnason Faktor ehf.

Number: 19

Paid: 24.5.2023

Expires: 9.6.2024

Payer: Árnason Faktor ehf.

Number: 20

Paid: 7.5.2024

Expires: 9.6.2025

Payer: Árnason Faktor ehf.

Upload documents

Email *

Reference number

Click here to upload document

EP1761528

5-amínó-2,4,7-tríoxó-3,4,7,8-tetrahýdró-2H-pýrídó(2,3-d)pýrimidín afleiður og skyld efnasambönd fyrir meðhöndlun á krabbameini

Status:

EP appl. date:

EP published:

EP application number:

EP translation filed:

Grant published:

EPO information:

Max expiry date:

Expiry date:

Title:

Timeline

Owner

Name:

Address:

Inventor

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Name:

Address:

Agent

Name:

Address:

Priority

Number:

Date:

Country:

Number:

Date:

Country:

Supplementary protection

SPC number:

Annual fees

Upload documents